NCT00322140View on ClinicalTrials.gov

CDDO to Treat Solid Tumors and Lymphomas

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

May 1, 2006

Primary Completion Date

January 14, 2008

Study Completion Date

January 14, 2008

Conditions
Solid TumorsLymphoma
Interventions
DRUG

CDDO

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00322140 - CDDO to Treat Solid Tumors and Lymphomas | Biotech Hunter | Biotech Hunter